30 Results for "

PEGylated constructs

" in MedChemExpress (MCE) Product Catalog:
Products (30)

30 Results for "PEGylated constructs" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-W591424
CAS No.: 92451-01-9
Synonyms: mPEG2000-SC; mPEG2000-Succinimidyl ester
m-PEG2000-NHS ester (mPEG2000-SC) is a reagent with both cell adhesion inhibition and peptide conjugation functions. The NHS ester group of m-PEG2000-NHS ester forms stable amide bonds with primary amine-containing molecules (e.g., the N-terminus of MMP-2-cleavable octapeptide) to generate mPEG-peptide intermediates for liposome surface modification. When m-PEG2000-NHS ester is immobilized on a cystamine-modified gold surface, it can construct an in vitro model for cell adhesion kinetic studies, and higher PEG density and thicker layers correlate with lower cell adhesion rates. m-PEG2000-NHS ester can synthesize MMP-2-responsive PEGylated lipid conjugates to achieve MMP-triggered dePEGylation in the tumor microenvironment. m-PEG2000-NHS ester can be used in studies related to colon cancer and other conditions .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-160041
CAS No.: 1390628-22-4
Synonyms: NOX-A12
Target:  

CXCR

Research Areas:  

Cancer

Olaptesed pegol (NOX-A12) is a L-oligoribonucleotide aptamer targeting CXCL12 based on a pegylated structure. Olaptesed pegol neutralizes CXCL12, and CXCL12 inhibition mobilizes chronic lymphocytic leukemia cells into the circulation and prevents their homing into the protective microenvironment. Olaptesed pegol can enhances the infiltration of human primary T cells and NK cells and inhibit tumor growth companied with anti-PD-1 antibody. Olaptesed pegol can be used for researches of colon cancer and lymphocytic leukemia .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-160041A
Synonyms: NOX-A12 sodium
Target:  

CXCR

Research Areas:  

Cancer

Olaptesed pegol (NOX-A12) sodium is a L-oligoribonucleotide aptamer targeting CXCL12 based on a pegylated structure. Olaptesed pegol sodium neutralizes CXCL12, and CXCL12 inhibition mobilizes chronic lymphocytic leukemia cells into the circulation and prevents their homing into the protective microenvironment. Olaptesed pegol sodium can enhances the infiltration of human primary T cells and NK cells and inhibit tumor growth companied with anti-PD-1 antibody. Olaptesed pegol sodium can be used for researches of colon cancer and lymphocytic leukemia .
loading...
    loading...
Cat. No.: HY-174972I
CAS No.: 205494-72-0
mPEG20000-DPPE is a PEGylated phospholipid containing DPPE. DOPE-mPEG750 combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
loading...
    loading...
Cat. No.: HY-112764B
CAS No.: 160743-62-4
mPEG350-DMG is a PEGylated phospholipid containing DMG. mPEG350-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
loading...
    loading...
Cat. No.: HY-112764C
CAS No.: 160743-62-4
mPEG500-DMG is a PEGylated phospholipid containing DMG. mPEG500-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
loading...
    loading...
Cat. No.: HY-112764D
CAS No.: 160743-62-4
mPEG750-DMG is a PEGylated phospholipid containing DMG. mPEG750-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
loading...
    loading...
Cat. No.: HY-112764E
CAS No.: 160743-62-4
mPEG30000-DMG is a PEGylated phospholipid containing DMG. mPEG30000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
loading...
    loading...
Cat. No.: HY-174972B
CAS No.: 205494-72-0
mPEG350-DPPE is a PEGylated phospholipid containing DPPE. mPEG350-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
loading...
    loading...
Cat. No.: HY-174972C
CAS No.: 205494-72-0
mPEG500-DPPE is a PEGylated phospholipid containing DPPE. mPEG500-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
loading...
    loading...
Cat. No.: HY-174972D
CAS No.: 205494-72-0
mPEG550-DPPE is a PEGylated phospholipid containing DPPE. mPEG550-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
loading...
    loading...
Cat. No.: HY-174972E
CAS No.: 205494-72-0
mPEG750-DPPE is a PEGylated phospholipid containing DPPE. mPEG750-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
loading...
    loading...
Cat. No.: HY-174972H
CAS No.: 205494-72-0
mPEG10000-DPPE is a PEGylated phospholipid containing DPPE. mPEG10000-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
loading...
    loading...
Cat. No.: HY-174972J
CAS No.: 205494-72-0
mPEG30000-DPPE is a PEGylated phospholipid containing DPPE. mPEG30000-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
loading...
    loading...
Cat. No.: HY-W1048624A
CAS No.: 308805-39-2
mPEG5000-DSG is a PEGylated phospholipid containing DSG. mPEG5000-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
loading...
    loading...
Cat. No.: HY-W1048624B
CAS No.: 308805-39-2
mPEG10000-DSG is a PEGylated phospholipid containing DSG. mPEG10000-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
loading...
    loading...
Cat. No.: HY-W1048624C
CAS No.: 308805-39-2
mPEG20000-DSG is a PEGylated phospholipid containing DSG. mPEG20000-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
loading...
    loading...
Cat. No.: HY-W1049054C
CAS No.: 160743-62-4
mPEG20000-DMG is a PEGylated phospholipid containing DMG. mPEG20000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
loading...
    loading...
Cat. No.: HY-W1052148B
CAS No.: 160743-62-4
mPEG10000-DMG is a PEGylated phospholipid containing DMG. mPEG10000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
loading...
    loading...
Cat. No.: HY-W1052148C
CAS No.: 160743-62-4
mPEG550-DMG is a PEGylated phospholipid containing DMG. mPEG550-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
loading...
    loading...